Cargando…

Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1

Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone card...

Descripción completa

Detalles Bibliográficos
Autores principales: Alì, Marco, Monti, Caterina Beatrice, Melazzini, Luca, Cardani, Rosanna, Fossati, Barbara, Cavalli, Michele, Chow, Kelvin, Secchi, Francesco, Meola, Giovanni, Sardanelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098463/
https://www.ncbi.nlm.nih.gov/pubmed/32265828
http://dx.doi.org/10.3389/fneur.2020.00192
_version_ 1783511185028546560
author Alì, Marco
Monti, Caterina Beatrice
Melazzini, Luca
Cardani, Rosanna
Fossati, Barbara
Cavalli, Michele
Chow, Kelvin
Secchi, Francesco
Meola, Giovanni
Sardanelli, Francesco
author_facet Alì, Marco
Monti, Caterina Beatrice
Melazzini, Luca
Cardani, Rosanna
Fossati, Barbara
Cavalli, Michele
Chow, Kelvin
Secchi, Francesco
Meola, Giovanni
Sardanelli, Francesco
author_sort Alì, Marco
collection PubMed
description Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone cardiac magnetic resonance at our center. Patients were age- and sex-matched with healthy controls. The Mann-Whitney U test was used to compare cardiac strain between the two groups. The t-test was used to compare the extracellular volume obtained in DM1 patients with that in healthy subject. Spearman's ρ was used for studying the associations among imaging parameters. Results: Global cardiac strain (median −19.1%; IQR −20.5%, −16.5%) in DM1 patients was lower (p = 0.011) than that in controls (median−21.7%; IQR−22.7%,-21.3%). Global extracellular volume in DM1 patients (median 32.3%; IQR 29.3%,36.8%) was significantly (p = 0.008) higher than that reported in literature in healthy subjects (median 25.6%; IQR 19.9%,31.9%). Global cardiac strain showed a strong, positive correlation with septal strain (ρ = 0.767, p = 0.016) and with both global (ρ = 0.733 p = 0.025) and septal extracellular volume (ρ = 0.767, p = 0.016). Discussion: The increase in cardiac extracellular volume and decrease in strain are signs of early cardiac pathology in DM1. Physicians dealing with DM1 may take into consideration cardiac magnetic resonance as a screening tool to identify early cardiac involvement in this condition.
format Online
Article
Text
id pubmed-7098463
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70984632020-04-07 Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1 Alì, Marco Monti, Caterina Beatrice Melazzini, Luca Cardani, Rosanna Fossati, Barbara Cavalli, Michele Chow, Kelvin Secchi, Francesco Meola, Giovanni Sardanelli, Francesco Front Neurol Neurology Introduction: To evaluate myocardial strain and extracellular volume in myotonic dystrophy type 1 (DM1) patients as potential imaging biomarkers of subclinical cardiac pathology. Materials and methods: We retrospectively analyzed 9 DM1 patients without apparent cardiac disease who had undergone cardiac magnetic resonance at our center. Patients were age- and sex-matched with healthy controls. The Mann-Whitney U test was used to compare cardiac strain between the two groups. The t-test was used to compare the extracellular volume obtained in DM1 patients with that in healthy subject. Spearman's ρ was used for studying the associations among imaging parameters. Results: Global cardiac strain (median −19.1%; IQR −20.5%, −16.5%) in DM1 patients was lower (p = 0.011) than that in controls (median−21.7%; IQR−22.7%,-21.3%). Global extracellular volume in DM1 patients (median 32.3%; IQR 29.3%,36.8%) was significantly (p = 0.008) higher than that reported in literature in healthy subjects (median 25.6%; IQR 19.9%,31.9%). Global cardiac strain showed a strong, positive correlation with septal strain (ρ = 0.767, p = 0.016) and with both global (ρ = 0.733 p = 0.025) and septal extracellular volume (ρ = 0.767, p = 0.016). Discussion: The increase in cardiac extracellular volume and decrease in strain are signs of early cardiac pathology in DM1. Physicians dealing with DM1 may take into consideration cardiac magnetic resonance as a screening tool to identify early cardiac involvement in this condition. Frontiers Media S.A. 2020-03-19 /pmc/articles/PMC7098463/ /pubmed/32265828 http://dx.doi.org/10.3389/fneur.2020.00192 Text en Copyright © 2020 Alì, Monti, Melazzini, Cardani, Fossati, Cavalli, Chow, Secchi, Meola and Sardanelli. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Alì, Marco
Monti, Caterina Beatrice
Melazzini, Luca
Cardani, Rosanna
Fossati, Barbara
Cavalli, Michele
Chow, Kelvin
Secchi, Francesco
Meola, Giovanni
Sardanelli, Francesco
Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title_full Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title_fullStr Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title_full_unstemmed Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title_short Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
title_sort rare disease: cardiac risk assessment with mri in patients with myotonic dystrophy type 1
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098463/
https://www.ncbi.nlm.nih.gov/pubmed/32265828
http://dx.doi.org/10.3389/fneur.2020.00192
work_keys_str_mv AT alimarco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT monticaterinabeatrice rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT melazziniluca rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT cardanirosanna rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT fossatibarbara rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT cavallimichele rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT chowkelvin rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT secchifrancesco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT meolagiovanni rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1
AT sardanellifrancesco rarediseasecardiacriskassessmentwithmriinpatientswithmyotonicdystrophytype1